Apellis Reports Positive Top-line Results from Phase 3 Head-to-Head Study of Pegcetacoplan (APL-2) Compared to Eculizumab in Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH)

Increasing Engagement

Mike Viscel

Bionical Solutions Group

Healthcare Challenger Brands

Frank X. Powers

Elevate Healthcare

Brand Nourishment

Stacey Gandler

Calcium+Company

Meeting Engagement

Pat Purcell

The Inception Company

Building Better Brands

John Tenaglia

Moon Rabbit

Success Coach

Bud Bilanich

University of Denver

Scientific Storytelling

Frank Burrell

Deerfield Agency

Programmatic Marketing

Thomas Shea

Doceree

Medication Adherence

Laura Blair

ConnectiveRx

Chief Executive Officer

Blake Shewey

Snow Companies

Unified Customer Experience

Anil Bhaskar

Asentech LLC

Omnidynamic Marketing

Matthew Durham

CMI Media Group’s

Increasing Engagement

Amy Giles

Bionical Solutions Group

Vice President

Natalie McGroarty

Global Sales Lippincott® HCP Access Solutions, Wolters Kluwer